---
layout: page
title: Publications
permalink: /Publications.html
---


**Selected Publication** 

1. Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, Takata K, Miyata-Takata T, Chung S, Rai S, Wu S, Warren M, Strong C, Goodyear T, Morris K, Chong LC, Hav M, Colombo AR, Telenius A, Boyle M, Ben-Neriah S, Power M, Gerrie AS, Weng AP, Karsan A, Roth A, Farinha P, Scott DW, Savage KJ, Nelson BH, Merchant A, Steidl C. Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma. J Clin Oncol. 2024 Mar 20;42(9):1077-1087. Epub 20231219. doi:10.1200/JCO.23.01115. Cited in: Pubmed; PMID 38113419.
2. Aoki T, Chong LC, Takata K, et al. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma. Proc Natl Acad Sci U S A 2021;118(41): e2105822118. DOI: 10.1073/pnas.2105822118.
3. Aoki T, Chong LC, Takata K, et al. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma. Cancer Discov 2020;10(3):406-421. DOI: 10.1158/2159-8290.CD-19-0680.
4. Sarkozy C, Wu S, Takata K, Aoki T, Neriah SB, Milne K, Goodyear T, Strong C, Rastogi T, Hilton LK, Lai D, Sehn LH, Farinha P, Nelson BH, Weng A, Marra M, Scott DW, Craig JW, Steidl C, Roth A. Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma. Cancer Cell. 2024 Jun 10;42(6):1003-1017.e6. doi: 10.1016/j.ccell.2024.05.011. PubMed PMID: 3886192
5. Aoki T, Steidl C. Novel insights into Hodgkin lymphoma biology by single-cell analysis. Blood. 2023 Apr 13;141(15):1791-1801. doi:10.1182/blood.2022017147. Cited in: Pubmed; PMID 36548960.
Maura F, Adams RM, Aoki T. Scientific techniques in adolescent and young adult classic Hodgkin lymphoma. EJHaem. 2023 Nov;4(4):902-907. The authors declare no conflicts of interest. Epub 20230929. doi:10.1002/jha2.786. Cited in: Pubmed; PMID 38024640.
6. Aoki T, Savage KJ, Steidl C. Biology in Practice: Harnessing the Curative Potential of the Immune System in Lymphoid Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021;39(5):346-360. DOI: 10.1200/JCO.20.01761.
7. Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, et al. Mutational landscape of gray zone lymphoma. Blood 2021;137(13):1765-1776. DOI: 10.1182/blood.2020007507.
Ennishi D, Healy S, Bashashati A, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, et al. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nat Med 2020;26(4):577-588. DOI: 10.1038/s41591-020-0757-z.
8. Laribi K, Baugier de Materre A, Sobh M, Cerroni L, Valentini CG, Aoki T,
9. Suzuki R, Takeuchi K, Frankel AE, Cota C, Ghez D, Le Calloch R, Pagano L, Petrella T. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv. 2020 Oct 13;4(19):4838-4848. doi: 10.1182/bloodadvances.2020002474. PubMed PMID: 33027528; PubMed Central PMCID: PMC7556130.
10. Zhang AW, O'Flanagan C, Chavez EA, Lim JLP, Ceglia N, McPherson A, Wiens M, Walters P, Chan T, Hewitson B, Lai D, Mottok A, Sarkozy C, Chong L, Aoki T, et al. Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling. Nat Methods 2019;16(10):1007-1015. DOI: 10.1038/s41592-019-0529-1.
11. Aoki T, Steidl C. Novel Biomarker Approaches in Classic Hodgkin Lymphoma. Cancer J 2018;24(5):206-214. DOI: 10.1097/PPO.0000000000000334.
